Londone \u012fsik\u016brusi augimo skolos valdytoja \u201eClaret Capital Partners\u201c prane\u0161\u0117 u\u017edariusi ketvirt\u0105j\u012f fond\u0105 \u201eClaret European Growth Capital Fund IV\u201c, kurio bendra suma pasiek\u0117 575 mln. eur\u0173. Tai daugiau nei pradinis 500 mln. eur\u0173 tikslas, o fondas skirtas investicijoms \u012f Europos technologij\u0173, gyvyb\u0117s moksl\u0173 ir poveikio sektorius.<\/p>\n
Bendra 575 mln. eur\u0173 suma sudaryta i\u0161 440 mln. eur\u0173 investuotoj\u0173 \u012fsipareigojim\u0173 pa\u010diame fonde ir 135 mln. eur\u0173 susijusio diskrecinio mandato. Bendrov\u0117 teigia, kad l\u0117\u0161as skyr\u0117 instituciniai investuotojai, tarp j\u0173 pensij\u0173 fondai, draudimo bendrov\u0117s ir \u0161eimos biurai, o dalis pritraukta ir per priva\u010dios bankininkyst\u0117s kanalus.<\/p>\n
\u201eClaret Capital Partners\u201c specializacija yra augimo skola, kai verslui suteikiamas finansavimas nesuma\u017einant akcinink\u0173 dalies taip, kaip tai nutinka pritraukiant nuosav\u0105 kapital\u0105. Tokie sprendimai ypa\u010d aktual\u016bs laikotarpiu, kai rizikos kapitalo rinka i\u0161lieka selektyvesn\u0117, o \u012fmon\u0117s ie\u0161ko b\u016bd\u0173 prailginti veiklos finansavimo laik\u0105 iki kito raundo.<\/p>\n
\u201eTai ne tik m\u016bs\u0173 po\u017ei\u016brio ir rezultat\u0173 patvirtinimas, bet ir didelis pasitik\u0117jimo balsas Europos technologij\u0173, gyvyb\u0117s moksl\u0173 ir poveikio ekosistemoms\u201c, \u2013 sak\u0117 \u201eClaret Capital Partners\u201c valdantysis partneris Davidas Batemanas.<\/p>\n
Bendrov\u0117s duomenimis, \u012fprast\u0173 paskol\u0173 dyd\u017eiai svyruoja nuo 2 mln. iki 100 mln. eur\u0173, o kiekvienas sandoris vertinamas individualiai. Kapitalas gali b\u016bti nukreiptas organiniam augimui, \u012fsigijimams, investicijoms \u012f \u012frang\u0105, apyvartin\u0117ms l\u0117\u0161oms, moksliniams tyrimams ir eksperimentinei pl\u0117trai bei pl\u0117trai \u012f naujas rinkas.<\/p>\n
\u201eClaret Capital Partners\u201c skelbia, kad jau panaudota 32 proc. fondo, paremta 27 \u012fmon\u0117s. Tarp \u012fvardijam\u0173 pavyzd\u017ei\u0173 yra \u201eBillie\u201c, \u201eCinclus Pharma\u201c, \u201ePRODA\u201c, \u201eInventiva\u201c ir \u201eSurfe\u201c.<\/p>\n
Valdytojas taip pat primena, kad nuo 2013 met\u0173 per fondus investavo daugiau nei 1,5 mlrd. eur\u0173 ir par\u0117m\u0117 per 210 bendrovi\u0173. Bendras nuo veiklos prad\u017eios pritrauktas kapitalas, anot bendrov\u0117s, siekia 1,3 mlrd. eur\u0173.<\/p>\n
\u201eKai nuosavo kapitalo rinka tampa i\u0161rankesn\u0117, o \u012fk\u016br\u0117jai ie\u0161ko augimo be nereikalingo akcij\u0173 i\u0161skiedimo, lankstaus finansavimo paklausa tur\u0117t\u0173 toliau augti\u201c, \u2013 sak\u0117 valdantysis partneris Johanas Kampe.<\/p>\n
Po galutinio fondo u\u017edarymo \u201eClaret Capital Partners\u201c planuoja toliau pl\u0117sti veikl\u0105 Europoje, stiprindama vietin\u0119 komand\u0105 pagrindiniuose inovacij\u0173 centruose. Bendrov\u0117 nurodo turinti komandos nari\u0173 Pary\u017eiuje ir planuojanti pl\u0117tr\u0105 Berlyne.<\/p>\n","protected":false},"excerpt":{"rendered":"
\u201eClaret Capital Partners\u201c u\u017edar\u0117 575 mln. eur\u0173 fond\u0105 Europos technologij\u0173 ir gyvyb\u0117s moksl\u0173 \u012fmon\u0117ms, o tre\u010ddalis l\u0117\u0161\u0173 jau panaudota.<\/p>\n","protected":false},"author":0,"featured_media":52472,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[94],"tags":[40620,40619,40621,6262,450,1040,40622],"miestas":[],"class_list":["post-52471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finansai","tag-augimo-skola","tag-claret-capital-partners","tag-gyvybes-mokslai","tag-investiciniai-fondai","tag-rizikos-kapitalas","tag-startuoliai","tag-technologiju-startuoliai"],"acf":[],"_links":{"self":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/52471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/comments?post=52471"}],"version-history":[{"count":0,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/52471\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media\/52472"}],"wp:attachment":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media?parent=52471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/categories?post=52471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/tags?post=52471"},{"taxonomy":"miestas","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/miestas?post=52471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}